PT  - JOURNAL ARTICLE
AU  - Turrisi, Rosanna
AU  - Forzanini, Federica
AU  - Stanziano, Mario
AU  - Nigri, Anna
AU  - Fedeli, Davide
AU  - Giovanna, Carrara
AU  - Laura, Lequio
AU  - Manera, Umberto
AU  - Moglia, Cristina
AU  - Valentini, Maria Consuelo
AU  - Calvo, Andrea
AU  - Chiò, Adriano
AU  - Barla, Annalisa
TI  - AI-based model for T1-weighted brain MRI diagnoses Amyotrophic Lateral Sclerosis
AID  - 10.1101/2024.04.26.24306438
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.26.24306438
4099  - http://medrxiv.org/content/early/2024/04/28/2024.04.26.24306438.short
4100  - http://medrxiv.org/content/early/2024/04/28/2024.04.26.24306438.full
AB  - Amyotrophic Lateral Sclerosis (ALS) is an incurable deadly motor neuron disease that causes the gradual deterioration of nerve cells in the spinal cord and brain. It impacts voluntary limb control and can result in breathing impairment. ALS diagnosis is often challenging due to its symptoms overlapping with other medical conditions and many tests must be performed to rule out other conditions, as easily identifiable biomarkers are still lacking. In this study, we explore T1-weighted (T1w) brain Magnetic Resonance Imaging (MRI), a non-invasive neuroimaging approach which has shown to be a reliable biomarker in many medical fields. Nonetheless, current literature on ALS diagnosis fails to retrieve evidence on how to identify biomarkers from T1w MRI.In this paper, we leverage Artificial Intelligence (AI) methods to unveil the unexplored potential of T1w brain MRI for distinguishing ALS patients from those who have similar symptoms but different diseases (mimicking). We consider a retrospective single-center dataset of brain T1-weighted MRIs collected from 2010 to 2018 recruited from the Piemonte and Valle d’Aosta ALS register (PARALS). The collection includes 548 patients with ALS and 106 with mimicking diseases. Our goal is to develop and validate a ML diagnostic model based exclusively on T1w MRI distinguishing the two classes. First, we extract a set of radiomic features and two sets of Deep Learning (DL)-based features from MRI scans. Then, using each representation, we train 8 binary classifiers. The best results were obtained by combining DL-based features with SVM classifier, reaching an F1-score of 0.91, and a Precision of 0.88, a Recall of 0.94, and an AUC of 0.7 considering the ALS group as the positive class in the testing set.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research project was mainly funded by the DECIPHER-ASL Bando PRIN 2017 grant (2017SNW5MB - Ministry of University and Research, Italy). This work is partially funded by the European Union - NextGenerationEU and by the Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), Mission 4, Component 2, Investment 1.5, project RAISE - Robotics and AI for Socio-economic Empowerment (ECS00000035) as A. Barla is part of the RAISE Innovation Ecosystem.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of "CET Interaziendale AOU Citta' della Salute e della Scienza di Torino" gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll codes produced in the present study are available at https://github.com/rturrisige/T1wMRI4ALS_diagnosis https://github.com/rturrisige/T1wMRI4ALS_diagnosis